Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
Stopped PI left institution. Study not moving forward in her absence.
Conditions
- Amyloidosis
- Light Chain (AL) Amyloidosis
Interventions
- DRUG: Bendamustine Hydrochloride
- DRUG: Isatuximab
Sponsor
Tufts Medical Center
Collaborators